Is there a rationale for combined TNF and IL-1 blocking in arthritis?
about
Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients?Immunomodulatory activity of a Chinese herbal drug Yi Shen Juan Bi in adjuvant arthritis.Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.Emerging immunotherapies for rheumatoid arthritis.Erlotinib and gefitinib, epidermal growth factor receptor kinase inhibitors, may treat non-cancer-related tumor necrosis factor-α mediated inflammatory diseases.
P2860
Is there a rationale for combined TNF and IL-1 blocking in arthritis?
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Is there a rationale for combined TNF and IL-1 blocking in arthritis?
@ast
Is there a rationale for combined TNF and IL-1 blocking in arthritis?
@en
type
label
Is there a rationale for combined TNF and IL-1 blocking in arthritis?
@ast
Is there a rationale for combined TNF and IL-1 blocking in arthritis?
@en
prefLabel
Is there a rationale for combined TNF and IL-1 blocking in arthritis?
@ast
Is there a rationale for combined TNF and IL-1 blocking in arthritis?
@en
P1476
Is there a rationale for combined TNF and IL-1 blocking in arthritis?
@en
P2093
W B van den Berg
P433
5 Suppl 27
P577
2002-09-01T00:00:00Z